Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Spinal interventions for cancer pain 

Spinal interventions for cancer pain
Chapter:
Spinal interventions for cancer pain
Author(s):

M.L. Sharma

DOI:
10.1093/med/9780199586912.003.0012
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 January 2021

Intrathecal neurolysis for cancer pain 228

Agents used for intrathecal neurolysis 230

Techniques 232

Postoperative care 236

In this chapter we focus on intrathecal (IT) neurolytic blockade for terminal cancer pain. There are no controlled studies, and so the literature is observational, case reports and book chapters reflecting the opinions of experienced clinicians. Many other interventions including spinal RF procedures, continuous epidural analgesia, IT pumps, and open or percutaneous cordotomy have a role in carefully selected patients, but these are beyond the scope of this chapter....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.